SPHDF OTC
Santhera Pharmaceuticals Holding AG
1W: -7.5%
1M: -21.3%
3M: -21.3%
YTD: +37.1%
1Y: +37.4%
3Y: +2591.2%
5Y: +115722.8%
$18.30
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$36M
-175.2% ▼
Capital Expenditures
$151K
+99.4% ▲
5Y CAGR: -8.0%
Free Cash Flow
-$36M
-251.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$11M
-63.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$67M | -$55M | -$71M | $55M | -$42M |
| Depreciation & Amort. | $7M | $4M | $10M | $3M | $6M |
| Stock-Based Comp. | $3M | $3M | $5M | $6M | $0 |
| Change in Working Capital | $3M | $18M | $9M | -$5M | -$14M |
| Other Non-Cash Items | $14M | $16M | $16M | -$11M | $15M |
| Operating Cash Flow | -$44M | -$37M | -$30M | $47M | -$36M |
| — Investing Activities — | |||||
| Capital Expenditures | -$34K | -$15K | -$4M | -$90K | -$151K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $2M | $84K | $24K | $6M | $90K |
| Other Investing | $0 | $0 | $0 | -$24M | $0 |
| Investing Cash Flow | $2M | $69K | -$4M | -$18M | -$61K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | $13M | $15M | -$18M | $21M |
| Stock Repurchased | -$922K | -$56K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $25M | $33M | -$1M | $2M | $25M |
| Financing Cash Flow | $23M | $46M | $14M | -$171K | $46M |
| Net Change in Cash | -$19M | $9M | -$20M | $29M | $11M |
| Cash End of Period | $12M | $21M | $1M | $30M | $41M |
| Free Cash Flow | -$44M | -$37M | -$34M | $24M | -$36M |